816 RIBAVIRIN DOSE REDUCTION DURING TELAPREVIR CONTAINING TRIPLE THERAPY DOES NOT AFFECT EARLY VIROLOGIC RESPONSE IN NON-RESPONDERS AND RELAPSERS WITH ADVANCED LIVER FIBROSIS
| Autor: | Janczewska, E., Flisiak, R., Berak, H., Zarebska-Michaluk, D., Dobracka, B., Pisula, A., Horban, A., Kryczka, W., Dobracki, W., Librant-Suska, M., Kozielewicz, D., Lojewski, W., Jurczyk, K., Lapinski, T., Musialik, J., Postawa-Klosinska, B., Wroblewski, J., Augustyniak, K., Dudziak, M., Olszok, I., Ruszala, A. |
|---|---|
| Zdroj: | In Journal of Hepatology April 2013 58 Supplement 1:S334-S335 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect